ライフサイエンスコーパス: monkeypox virus

1 une regime (69 U/ml) prior to challenge with monkeypox virus.

2 ion from a lethal intravenous challenge with monkeypox virus.

3 a, vaccinia, camelpox, mousepox, cowpox, and monkeypox virus.

4 d new and emerging infectious agents such as monkeypox virus.

5 ase after an otherwise lethal challenge with monkeypox virus.

6 omolgus macaques were exposed to aerosolized monkeypox virus (10(5) PFU).

7 revented spread of vaccinia virus as well as monkeypox virus, a human pathogen.

8 re essential for protection of macaques from monkeypox virus, a variola virus ortholog.

9 thogenic orthopoxviruses like variola virus, monkeypox virus, and cowpox virus (CPXV), but not vaccin

10 (HSV-2), human immunodeficiency virus (HIV), monkeypox virus, and hepatitis B virus.

11 accinia virus, the emerging infectious agent monkeypox virus, and the potential biothreat variola vir

12 reexpansion in association with sterile anti-monkeypox virus (anti-MPV) immunity after MPV challenge.

13 causative agent of smallpox, and the related monkeypox virus are both select agents that, if purposef

14 The prairie dog, using monkeypox virus as a challenge virus, has provided a val

15 macaques were challenged intravenously with monkeypox virus at 4, 6, 10, and 30 days after immunizat

16 enetic constrains are sufficient to diminish monkeypox virus' capacity for enhanced specificity as a

17 e macaques were not protected against lethal monkeypox virus challenge if their CD4(+) cell count was

18 th MVA provided protection for >2 years in a monkeypox virus challenge model.

19 us compound ST-246 in prairie dogs against a monkeypox virus challenge of 65 times the 50% lethal dos

20 Recent monkeypox virus challenge studies have established the b

21 could be boosted as a recall response after monkeypox virus challenge.

22 ception, exhibiting extreme vulnerability to monkeypox virus, cowpox virus, and vaccinia virus and th

23 odeoxyglucose ([(18)F]-FDG) in monkeys after monkeypox virus exposure to monitor the immune response

24 ocuments the isolation and identification of monkeypox virus from humans in the Western Hemisphere.

25 Cowpox and monkeypox viruses have taken an alternate approach by en

26 ain reaction and culture revealed infectious monkeypox virus in skin lesions of all 3 patients; 2 pat

27 ed a valuable nonhuman animal model in which monkeypox virus infection closely resembles human system

28 Monkeypox virus infection of nonhuman primates (NHPs) pr

29 Monkeypox virus infection results in a systemic, febrile

30 One year after monkeypox virus infection, 6 of 7 individuals had IFN- g

31 ted with VV, 7 individuals with a history of monkeypox virus infection, and 8 individuals with a hist

32 Understanding the mechanisms of monkeypox virus innate immune evasion will help us to un

33 Subsequent monkeypox virus intranasal infection of vaccinated prair

34 Monkeypox virus is a less efficient human pathogen than

35 Monkeypox virus is an emerging, zoonotic orthopoxvirus w

36 uses smallpox) is the most pathogenic, while monkeypox virus is intermediate in pathogenicity between

37 Monkeypox virus (MPV) is a virulent human pathogen that

38 monstrate that the Poxviridae family members monkeypox virus (MPX) and variola virus (VarV) use conse

39 Infection with monkeypox virus (MPXV) causes disease manifestations in

40 While the monkeypox virus (MPXV) genome encodes a homologue of the

41 Monkeypox virus (MPXV) infection has recently expanded i

42 Monkeypox virus (MPXV) is a human pathogen that is a mem

43 Monkeypox virus (MPXV) is an orthopoxvirus closely relat

44 Monkeypox virus (MPXV) is an orthopoxvirus closely relat

45 Infection of nonhuman primates (NHPs) with monkeypox virus (MPXV) is currently being developed as a

46 Monkeypox virus (MPXV) is endemic in Africa, where it ca

47 Monkeypox virus (MPXV) is endemic within Africa where it

48 The 2003 monkeypox virus (MPXV) outbreak and subsequent laborator

49 To better understand the occurrence of monkeypox virus (MPXV), an emerging Orthopoxvirus in hum

50 e United States following the importation of monkeypox virus (MPXV)-infected animals in a consignment

51 erging zoonotic infectious disease caused by Monkeypox virus (MPXV).

52 protein (OMCP) is conserved among cowpox and monkeypox viruses, secreted by infected cells, and bound

53 elting temperature [T(m)], 56.40 degrees C), monkeypox virus (T(m), 56.24 degrees C), and vaccinia vi

54 (m)s, 61.7 to 62.7 degrees C), 15 strains of monkeypox virus (T(m)s, 61.9 to 62.2 degrees C), 40 stra

55 nt of smallpox (variola virus), the zoonotic monkeypox virus, the vaccine and zoonotic species vaccin

56 After challenge with monkeypox virus, unimmunized animals developed more than

57 Monkeypox virus was recovered in cell cultures of seven

58 uring human infections with the smallpox and monkeypox viruses, which are highly homologous to ectrom

59 % identity in all orthopoxviruses except for monkeypox viruses, whose O3 homologs have 2 to 3 amino a